Intratumoral Targeted Hyperthermia Therapy (THT)

· Sona Nanotech Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Intratumoral Targeted Hyperthermia Therapy (THT), covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Intratumoral Targeted Hyperthermia Therapy (THT) for Cutaneous Metastatic Melanoma [NA]